Published on 1 May 2024 on Benzinga
In a historic trading session on Tuesday, cannabis stocks soared following the DEA's reported decision to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act.
This regulatory shift, which would align with a recommendation from the Department of Health and Human Services sparked investor interest